Genscript Biotech Corporation
GNNSF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $293 | $132 | $399 | $1,479 |
| Short-Term Investments | $104 | $489 | $1,475 | $482 |
| Receivables | $132 | $119 | $131 | $300 |
| Inventory | $39 | $31 | $51 | $53 |
| Other Curr. Assets | $45 | $64 | $159 | $72 |
| Total Curr. Assets | $1,177 | $835 | $2,214 | $2,353 |
| Property Plant & Equip (Net) | $598 | $603 | $814 | $751 |
| Goodwill | $1 | $1 | $1 | $1 |
| Intangibles | $13 | $13 | $16 | $19 |
| Long-Term Investments | $3,609 | $3,301 | $102 | $91 |
| Tax Assets | $0 | $28 | $0 | $17 |
| Other NC Assets | $37 | $498 | $185 | $173 |
| Total NC Assets | $4,258 | $4,443 | $1,118 | $1,052 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $5,435 | $5,278 | $3,332 | $3,386 |
| Liabilities | – | – | – | – |
| Payables | $52 | $30 | $59 | $40 |
| Short-Term Debt | $164 | $96 | $45 | $66 |
| Tax Payable | $0 | $15 | $16 | $18 |
| Deferred Revenue | $0 | $0 | $0 | $92 |
| Other Curr. Liab. | $385 | $166 | $413 | $279 |
| Total Curr. Liab. | $601 | $307 | $533 | $495 |
| LT Debt | $385 | $74 | $403 | $351 |
| Deferred Rev, NC | $0 | $0 | $3 | $48 |
| Deferred Tax Liab, NC | $14 | $6 | $8 | $6 |
| Other NC Liab. | $28 | $567 | $562 | $443 |
| Total NC Liab. | $413 | $648 | $975 | $848 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $63 | $65 | $112 | $73 |
| Total Liabilities | $1,013 | $955 | $1,508 | $1,343 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $2 | $2 | $2 | $2 |
| Retained Earnings | $2,339 | $2,350 | -$773 | -$632 |
| AOCI | $96 | -$21 | $19 | $92 |
| Other Equity | $1,979 | $1,975 | $1,966 | $1,929 |
| Total Equity | $4,416 | $4,321 | $1,215 | $1,391 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $5 | $2 | $609 | $653 |
| Total Liab. & Tot. Equity | $5,435 | $5,278 | $3,332 | $3,386 |
| Net Debt | $255 | $39 | $49 | -$1,062 |